Helix BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Oct '25 Oct 21, 2025	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	2016 - 2020
Market Capitalization	118	57	41	32	25	94	Upgrade
Market Cap Growth	153.25%	40.48%	27.81%	25.38%	-72.89%	75.26%	Upgrade
Enterprise Value	118	57	40	31	26	92	Upgrade
Last Close Price	1.73	0.60	0.83	0.72	0.77	3.58	Upgrade
PB Ratio	10.30	5.09	-626.39	-49.71	102.32	-84.09	Upgrade
P/TBV Ratio	-	-	-	-	102.32	-	Upgrade
Debt / Equity Ratio	0.02	0.02	-	-	7.74	-2.59	Upgrade
Quick Ratio	0.18	0.06	0.72	0.46	1.03	1.01	Upgrade
Current Ratio	0.23	0.13	0.92	0.53	1.08	1.04	Upgrade
Return on Equity (ROE)	-66.34%	-67.18%	-	-	-	-1205.79%	Upgrade
Return on Assets (ROA)	-30.36%	-33.25%	-458.65%	-166.12%	-96.84%	-127.23%	Upgrade
Return on Capital (ROIC)	-39.28%	-42.61%	-	-407.18%	-150.82%	-212.98%	Upgrade
Return on Capital Employed (ROCE)	-29.40%	-34.60%	10265.60%	748.60%	-1887.50%	-4780.60%	Upgrade
Earnings Yield	-2.95%	-6.56%	-16.43%	-14.97%	-20.11%	-6.86%	Upgrade
FCF Yield	-2.54%	-4.83%	-9.28%	-13.18%	-19.94%	-7.94%	Upgrade
Buyback Yield / Dilution	-35.46%	-25.29%	-15.11%	-29.26%	-8.41%	-7.97%	Upgrade

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.